Joint Polish Investment Fund

Joint Polish Investment Fund Management B.V., established in 2015, is a Warsaw-based venture capital firm focused on investing in life science companies, particularly in medical technology, mobile health, and diagnostics. The firm targets early to mid-stage companies primarily located in Central and Eastern Europe, with a specific emphasis on Poland. Investments range from $0.26 million to $4 million per company, with a typical holding period of three to five years. The fund supports innovations in areas such as medical devices, drug development, and chronic disease monitoring, while also considering companies with foreign technology partnerships. Joint Polish Investment Fund boasts a team with extensive expertise in both the life sciences and business sectors, providing entrepreneurs access to valuable insights and a global network to enhance their development and market entry into key healthcare markets, including Europe, the United States, and Asia.

Kreske Nickelsen

General Partner and CEO

Marek Orlowski

General Partner

Axel Polack

General Partner

9 past transactions

DreamJay

Series A in 2017
DreamJay Inc. is a Berkeley, California-based company that specializes in developing digital solutions aimed at improving sleep quality. Founded in 2015, the company created the Nightly app, which employs innovative sleep stimulation techniques to help users fall asleep more easily, reduce the frequency of awakenings, and minimize bad dreams. The application is particularly beneficial for individuals with sleep disorders, as it offers a non-pharmaceutical approach to managing sleep issues. By waking users during the lightest stage of sleep, Nightly enhances overall sleep efficiency, contributing to a healthier and more positive waking experience.

Nightly

Series A in 2017
Nightly helps you enjoy healthy sleep. It actively works to keep your night restful in three ways: it helps you easily fall asleep, limit bad dreams and reduce the likelihood of nighttime awakenings. This innovative, scientifically-developed technology is a combination of two factors: audio-visual stimuli and advanced AI algorithms. Nightly monitors your sleep live, recognizes critical moments during your night and reacts with soothing sounds to help you minimize the possibility of a wakeup. It stimulates your sleep to help you keep your rest uninterrupted.

Smartmedics

Venture Round in 2017
Smartmedics is a digital healthcare company based in Warsaw, Poland, specializing in advanced electrocardiogram systems. The company combines expertise in research and development, design, engineering, data science, and clinical practice to create innovative healthcare solutions. Smartmedics has developed a device that monitors biosignal parameters through smartphones, utilizing wireless, radiolucent algorithms to analyze the data. This technology enables users to detect cardiac abnormalities, facilitating home monitoring and cardiac telerehabilitation. Through its focus on making biosignals transparent, Smartmedics aims to enhance patient care and improve health outcomes.

Fixnip

Venture Round in 2017
Fixnip Ltd is a medical device company based in Even Yehuda, Israel, established in 2015. It specializes in the development of innovative hypodermic silicone nipple implants aimed at enhancing breast reconstruction and addressing inverted nipples. The implants utilize a nitinol skeleton combined with soft medical silicone casting, ensuring a reliable structure that is both soft and flexible while mimicking a natural appearance. Fixnip’s products aim to offer physicians a global standard of care for nipple reconstruction, enabling women to regain self-confidence following procedures such as post-mastectomy reconstruction or aesthetic enhancement. The company’s focus on creating implants with a softer feel and a natural look positions it as a significant player in the field of breast augmentation and reconstruction.

PHase2 Micro Technologies

Venture Round in 2016
PHase2 Micro Technologies is a technology development company that offers MEMS-enabled pH sensor technology platforms. PHase2 Micro Technologies’ AccuMET™ pH sensing platforms include single measurement chips (SMCs) designed for discrete single measurements as well as multiple measurement chips (MMCs). They also include continuous self-calibrating chips (CSCs), which are designed to use in continuous monitoring applications. PHase2 Micro Technologies is based in Boston, Massachusetts.

ScaleThings

Venture Round in 2016
ScaleThings Sp. z o.o. develops tactile-sensing weighing technologies embedded in a diverse range of consumer retail products for home, wearables, health, and baby care. The company manufactures ScaleThin Rug, a body fat analyzer scale embedded in a bath rug which provides a weighing scale along with a buzzer for optimal brushing time. The company's rug can be integrated with a mobile application and bluetooth for tracking all measurements. ScaleThings Sp. z o.o. was incorporated in 2014 and is based in Zyrardow, Poland with a post-office box location in Warsaw, Poland.

AioCare

Seed Round in 2016
MySpiroo by Healthup - Ultraportable spirometer The MySpiroo is a spirometer, a device which helps to control asthma, reduces the number of exacerbations and protects from life-threatening attacks.

Manta Instruments

Series A in 2015
MANTA Instruments Inc. (MANTA) is commercializing scientific instruments that use breakthrough technology to characterize nanoparticles much more effectively than existing products. Existing instruments for characterizing nanoparticles are unable to: i) adequately measure concentration of nanoparticles, ii) measure samples with mixed nanoparticle sizes, and iii) reliably measure changes in nanoparticle size over time.

Sound Object Technologies

Seed Round in 2015
Sound Object Technologies is develops technology for obtaining and processing information from sound signals for application in medical devices.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.